NIOSHTIC-2 Publications Search
In vivo reduction of chromium (VI) and its related free radical generation.
Mol Cell Biochem 2001 Jun; 222(1-2):41-47
Chromium (VI) compounds are widely recognized as human carcinogens. Extensive studies in vitro and in model systems indicate that the reactive intermediate, Cr (V), generated by cellular reduction of Cr (VI), is likely the candidate for the ultimate carcinogenic form of chromium compounds. Here we review our current understanding of the in vivo reduction of Cr (VI) and its related free radical generation. Our results demonstrate that Cr (V) is indeed generated from the reduction of Cr (VI) in vivo, and that Cr (V) thus formed can mediate the generation of free radicals. Cr (V) and its related free radicals are very likely to be involved in the mechanism of Cr (VI)-induced toxicity and carcinogenesis. These studies also illustrate that in vivo EPR spectroscopy and magnetic resonance imaging can be very useful and powerful tools for studying paramagnetic metal ions in chemical and biochemical reactions occurring in intact animals.
Free-radicals; Chromium-compounds; Carcinogens; Metallic-ions; In-vivo-studies; Free-radical-generation; In-vitro-studies; Models; Carcinogenesis; Carcinogenicity; Biochemical-analysis
Issue of Publication
Molecular and Cellular Biochemistry
Page last reviewed: April 12, 2019
Content source: National Institute for Occupational Safety and Health Education and Information Division